Navigation Links
Conseco Reports First Quarter Results
Date:5/7/2008

lated to a

litigation settlement 48.1 49.3

Costs related to a litigation settlement - (13.0)

Total EBIT 48.1 36.3

Corporate interest expense (16.4) (16.1)

Income before net realized investment losses

and taxes 31.7 20.2

Tax expense on period income 11.0 7.0

Net income before net realized investment

losses 20.7 13.2

Preferred stock dividends:

5.50% Class B mandatorily convertible

preferred stock - (9.5)

Net operating income 20.7 3.7

Net realized investment losses, net of

related amortization and taxes (26.5) (13.7)

Net income (loss) applicable to common stock $(5.8) $(10.0)

Per diluted share:

Net operating income $.11 $.02

Net realized investment losses, net of

related amortization and taxes (.14) (.09)

Net loss applicable to common stock $(.03) $(.07)

In our Bankers Life segment, pre-tax operating earnings were $29.1 million in the first quarter of 2008, compared to $45.5 million in the first quarter of 2007. Results for the first quarter of 2008 were affected by:
-- a reduction in earnings of approximately $10 million resulting from an

increase in the interest-adjusted benefit ratio on long-term care

policies primarily driven by higher claim expenses;

-- a reduction in earnings of approximately $7 million related to equity-

indexed annuity products (such variance primarily result
'/>"/>

SOURCE Conseco, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Insurance Department Fines Conseco Under Pennsylvania-Led, Multi-State Agreement
2. Conseco Reaches Settlement of Multistate Market Conduct Examination
3. Conseco Sets Earnings Release Date
4. Bischof Promoted to Vice President, Enterprise Risk Management at Conseco
5. Conseco Reports Fourth Quarter and Year-End Results
6. Conseco Files 10-K and Sets Earnings Release Date
7. Conseco Reports Preliminary Fourth Quarter and Year-End Results
8. Conseco Declines Partnerships Request for Board Seats; Review of Strategic Alternatives Underway
9. Conseco Files to Formally Extend Due Date for Annual Report on Form 10-K to March 17 and Reschedules Earnings Release and Investor Call
10. Hacker Joins Conseco as Senior Vice President and Treasurer
11. Tongson Joins Conseco as Senior Vice President, Corporate Actuarial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... (PRWEB) December 22, 2014 Weddingshe.com, an ... occasion gowns, has recently released its new selection of ... models are made according to the newest fashion trends. ... stunning dresses for cocktail parties . All of ... 80 percent off. We are making every effort to ...
(Date:12/21/2014)... New York (PRWEB) December 21, 2014 ... and other product liability claims involving a class ... mimetics continue to move forward in a federal ... Southern District of California, Bernstein Liebhard LLP reports. ... Court has established a data cut-off date of ...
(Date:12/21/2014)... 21, 2014 Serious Buyer, Andrew Hawley ... Jm Morrison and the Doors International Ballroom at the ... also be the only time that Morrison's mother would ... Nov. 25, 1967. According to Hawley, “This would be ... play the Alexandria Roller Rink earlier that year and ...
(Date:12/21/2014)... As testosterone therapy lawsuit filings ... and blood clots from using testosterone products such as ... shows that the male hormone testosterone may increase the ... published in the Proceedings of the National Academy of ... group of male rats with naturally occurring colon cancer. ...
(Date:12/20/2014)... 21, 2014 BambooIndustry.com is ... the business has announced its bamboo flooring promotion ... best material from certified suppliers, and offers the ... worldwide. In the current promotion, all customers can ... when they say they know BambooIndustry.com from press ...
Breaking Medicine News(10 mins):Health News:Stunning Cocktail Party Dresses from Weddingshe.com 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2
... by the U.S. Centers for Disease Control and Prevention says ... defects in the country.// ,"It helps to understand ... import they have on families around the country," said Joann ... of Dimes Birth Defects Foundation in White Plains, New York. ...
... has licensed Sildenafil to trade under the name Revatio ... pulmonary hypertension// specialist Ardeschir Ghofrani has revealed that Sildenafil ... a pill that has a positive effect in the ... aeration and improves the intake of oxygen in the ...
... are more prone to depression than men, and this may ... in the American Journal of Psychiatry.// In the January issue ... is higher in women than in men, where it is ... at the Karolinska Institute in Sweden, represents the largest epidemiological ...
... adults are of the opinion, that it is imperative ... Schools//, according to a survey, by the San Francisco-based ... opted for programs with information on abstinence from sex, ... on mere abstinence programs. At least one program on ...
... and Jared Kennedy are the parents of the first baby born ... purchased from a commercial egg bank, Cryo Eggs// International (CEI), which ... the seven eggs were purchased for US$ 2,500 by the couple. ... three eggs which were implanted in Wendy. There is only a ...
... United States has asked the US Food and Drug Administration ... treatment of Attention Deficit Hyperactivity Disorder (ADHD) following reports that ... as strokes and heart attacks. The US committee would meet ... drugs. The Therapeutic Goods Administration (TGA) in Australia is responsible ...
Cached Medicine News:Health News:US Government Licenses New Hypertension Drug 2
(Date:12/17/2014)... , December 17, 2014 ... nothing less than a hub of information concerning the biopharmaceutical ... A further addition to the recently launched institutional ... and has now been enriched by a new chapter in ... A richly detailed and panoramic hub on the ...
(Date:12/17/2014)...  RXi Pharmaceuticals Corporation (NASDAQ: RXII ... and commercializing innovative therapies addressing major unmet medical ... in its first Phase 2a study, RXI-109-1301.  The ... 1-month findings that were reported in September of ... http://photos.prnewswire.com/prnh/20130917/NE80755LOGO , , , ...
(Date:12/15/2014)... Registreer nu via  http://bit.ly/ag8Sypm14de ... Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen (PMR) ... PROGRAMM ™ 2015 in Amsterdam ... Tagung soll dazu beitragen, der Aegate PMR ... profitablen Unternehmensdienstleistungen, die für Apotheken und die ...
Breaking Medicine Technology:Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2
... 2010 AstraZeneca (NYSE: ... it will discontinue the development of CERTRIAD™ (rosuvastatin calcium and ... mixed dyslipidemia. This means the co-development and license agreement with ... A Complete Response Letter (CRL) for the CERTRIAD New Drug ...
... Inc (NYSE: PFE ) today announced that ... States Food and Drug Administration (FDA) and the European ... 13®* (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to ... prevention of pneumococcal disease caused by the 13 serotypes ...
Cached Medicine Technology:Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 2Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 3Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 4Pfizer Submits Applications to FDA and EMA for Use of its Pneumococcal Conjugate Vaccine, Prevnar 13®, in Adults 50 and Older 5
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: